Corporate Overview

Driven By Technology, Guided By Experience

For pharmaceutical, biotech and research organizations that need to accelerate the right medicines to market, Cmed Group is an innovative clinical trials company that specializes in providing state-of-the-art technology products and diverse services. Unlike separate eClinical technology and contract research organization (CRO) vendors, Cmed Group takes a flexible and efficient approach in providing the right solution that meets our customers’ changing needs and expectations. As a result, Cmed Group expedites clinical trials operations to provide immediate real-world results for clinical trial sponsors through its two divisions: Cmed Clinical Services, a full-service CRO; and Cmed Technology, an eClinical technology provider.

Central to its businesses is Timaeus, a unified on-demand platform that supports Study Design through Reporting. Timaeus is a unified eClinical platform for electronic trial design, electronic data capture (EDC), monitoring, medical coding, data management (for electronic, paper and hybrid trials) and real-time reporting. Its unique architecture uses advanced distributed computing and mobile technologies to give study teams the freedom and flexibility to access clinical trial data from anywhere at anytime as well as manage any type of data for any protocol.

While Cmed Technology maintains and enhances Timaeus, Cmed Clinical Services provides a wide range of services around this innovative on-demand eClinical platform.

Established in early 2000, Cmed Group has grown to more than 300 professionals located primarily in Europe and the United States. Cmed Group’s main headquarters is in Horsham, UK. It has additional offices in Timisoara, Romania; Murray Hill, NJ USA and Durham (Research Triangle Park), NC USA.

Vision Statement

Optimizing drug development through the creation of innovative, strategic partnerships